SEC Tracker
Get the app

Regeneron Pharmaceuticals REGN

Huda Y Zoghbi (Director) plans to sell 1,638 REGN shares, about $1.3M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Feb 19, 2026
  2. Broker: UBS Financial Services, Inc.
  3. Shares acquired by: Exercise of stock options
  4. 10b5-1 plan adopted: Nov 20, 2025

All of Huda Y Zoghbi's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 49 shares at $774.68 on Feb 19, 2026 · Form 4
  • Sold 50 shares at $775.5 on Feb 19, 2026 · Form 4
  • Sold 53 shares at $778.47 on Feb 19, 2026 · Form 4
  • Sold 208 shares at $779.55 on Feb 19, 2026 · Form 4
  • Sold 331 shares at $780.45 on Feb 19, 2026 · Form 4
  • Sold 209 shares at $781.28 on Feb 19, 2026 · Form 4
  • Sold 298 shares at $782.1 on Feb 19, 2026 · Form 4
  • Sold 220 shares at $783.29 on Feb 19, 2026 · Form 4
  • Sold 160 shares at $784.45 on Feb 19, 2026 · Form 4
  • Sold 56 shares at $785.61 on Feb 19, 2026 · Form 4
  • Sold 4 shares at $790 on Feb 19, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Regeneron Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Zoetis ZTS public float $69.2B, Jun 30, 2025
  2. Idexx Laboratories IDXX public float $42.9B, Jun 30, 2025
  3. Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025
  4. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
  5. Gilead Sciences GILD public float $103.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.